Evaluation of Charlson comorbidity index as predictor of survival in stage II-III colorectal cancer patients treated with surgery and neoadjuvant/adjuvant chemotherapy: A single Institution observational study

被引：0
|
作者：
Baretti, M. [1 ]
Personeni, N. [1 ]
Giordano, L. [1 ]
Tronconi, M. C. [1 ]
Pressiani, T. [1 ]
Bozzarelli, S. [1 ]
Rimassa, L. [1 ]
Santoro, A. [2 ]
机构：
[1] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Rozzano, Italy
[2] Humanitas Univ, Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Rozzano, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw370.104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
556P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of comorbidity in stage II-III colorectal cancer (CRC) patients treated with surgery and neoadjuvant/adjuvant chemotherapy: a single Institution observational study
    Baretti, M.
    Giordano, L.
    Rimassa, L.
    Tronconi, M. C.
    Pressiani, T.
    Bozzarelli, S.
    Personeni, N.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Predictors of survival in stage III colorectal cancer patients treated with surgery and adjuvant chemotherapy: A single institution observational study
    Chiang, K. M.
    Lu, W-C.
    Wu, H.
    Hsueh, F. J.
    Chen, J. P.
    ANNALS OF ONCOLOGY, 2022, 33 : S1451 - S1451
  • [3] Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study
    Baretti, Marina
    Rimassa, Lorenza
    Personeni, Nicola
    Giordano, Laura
    Tronconi, Maria Chiara
    Pressiani, Tiziana
    Bozzarelli, Silvia
    Santoro, Armando
    CLINICAL COLORECTAL CANCER, 2018, 17 (03) : E489 - E498
  • [4] Glycemic Variability in Patients With Stage II-III Colon Cancer Treated With Surgery and Adjuvant Chemotherapy
    Mandolfo, Natalie Rasmussen
    Berger, Ann M.
    Struwe, Leeza A.
    Shade, Marcia Y.
    Goldner, Whitney
    Klute, Kelsey
    Langenfeld, Sean J.
    Hammer, Marilyn J.
    ONCOLOGY NURSING FORUM, 2022, 49 (06) : 571 - 584
  • [5] A single-centre experience of adjuvant oxaliplatin based chemotherapy in elderly stage II-III colorectal cancer patients
    Reed, H.
    Wooden, A.
    de Winton, E.
    Gangadhara, S.
    Cox, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S160 - S160
  • [6] Cyclin E as a prognostic marker and predictor of response to neoadjuvant chemotherapy and adjuvant hormonal therapy in patients with stage II-III breast cancer
    Karakas, Cansu
    Francis, Ashleigh
    Yi, Min
    Sahin, Aysegul
    Keyomarsi, Khandan
    Hunt, Kelly
    CANCER RESEARCH, 2015, 75
  • [7] Internal Mammary Node Irradiation Improves Survival for Patients with Clinical Stage II-III Breast Cancer and Treated with Neoadjuvant Chemotherapy
    Luo, J.
    Jin, K.
    Chen, X.
    Yang, Z.
    Zhang, L.
    Mei, X.
    Ma, J.
    Zhang, Z.
    Shao, Z.
    Yu, X.
    Guo, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S217 - S217
  • [8] Adjuvant FOLFOX Chemotherapy and Splenomegaly in Patients with Stages II-III Colorectal Cancer
    Angitapalli, Revathi
    Litwin, Alan M.
    Kumar, Prasanna R. G.
    Nasser, Eiad
    Lombardo, Jeffrey
    Mashtare, Terry
    Wilding, Gregory E.
    Fakih, Marwan G.
    ONCOLOGY, 2009, 76 (05) : 363 - 368
  • [9] Role of adjuvant chemotherapy in patients with stage II-III ampullary cancer.
    Semenov, Nikolay
    Zhukova, Lyudmila
    Grechukhina, Katerina
    Izrailov, Roman
    Dalgatov, Kamil
    Khatkov, Igor
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 508 - 508
  • [10] Neoadjuvant chemotherapy for stage II-III breast cancer: a single-center experience
    Zaher, Haidi Abd El
    Fathy, Hamada
    Abozeid, Mohamed
    Faisal, Mohammed
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
12345